-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

301.O1.6 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: The Multimodal Platelet; Discovery of Novel Platelet Functions and Applications From Cancers to Thrombocytopenias

Symposia: Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Bleeding and Clotting, autoimmune disorders, Biological therapies, Translational Research, Non-Biological therapies, platelet disorders, Chimeric Antigen Receptor (CAR)-T Cell Therapies, genomics, bioinformatics, drug development, Diseases, thrombocytopenias, Immune Disorders, Therapies, Biological Processes, molecular biology, Technology and Procedures, profiling
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Room 33 (San Diego Convention Center)
Moderators:
Kellie R. Machlus, PhD, Boston Children's Hospital and Harvard Medical School and Karl Desch, MD, University of Michigan
Disclosures:
No relevant conflicts of interest to declare.
The purpose of Oral Session 301 is to present new discoveries in platelet function and new platelet targets for the treatment of platelet related disorders. The theme includes new platelet functions including their sequestration of circulating tumour DNA and a protective role in lung cancer metastasis. The theme also includes new platelet protein function (actinin) and platelet transcripts. It also includes 2 potential therapeutic targets for immune thrombocytopenia (targeting autoreactive B cells and mitophagy).
4:00 PM

Lauren Murphy, BSc1*, Jeanne Inchauspe2*, Nikolaos Sousos3*, Natalie Jooss4*, Hayley L Belnoue-Davis5*, Pamela Holland6*, Rong Li, PhD7*, Giampiero Valenzano8*, Fenella Roseman9*, Sujata Biswas7*, Sally-Ann Clark, BSc, PhD1*, Jennifer O'Sullivan10*, Michael Rimmer11*, Abdullah O Khan12*, Christina Simoglou Karali1*, Eric ONeill8*, Nadia Nasreddin13*, Ian Hitchcock14, Milka Koupenova15*, Manu Vatish16*, Paul Rees17*, Simon Leedham13*, Adam J Mead, MRCP, FRCPath, PhD1, Benjamin Schuster-Boeckler18*, Christopher Gregory19* and Bethan Psaila, MD, PhD20

1Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, National Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
2University of Oxford, MRC WIMM, Oxford, United Kingdom
3Haematopoietic Stem Cell Biology Laboratory, Medical Research Council Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
4University of Oxford, WIMM, Oxford, United Kingdom
5Wellcome Centre for Human Genetics, University of Oxford,, Oxford, United Kingdom
6University of Edinburgh, Centre for Inflammation Research, Institute for Regeneration and Repair, Edinburgh, United Kingdom
7University of Oxford, Oxford, United Kingdom
8Department of Oncology, University of Oxford, Oxford, United Kingdom
9Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom
10Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
11Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom
12MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
13Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
14York Biomedical Research Institute (YBRI), Department of Biology, University of York, York, United Kingdom
15University of Massachusetts Medical School, Worcester, MA
16Oxford University Hospitals Foundation Trust, Oxford, GBR
17Department of Physics, Swansea University, Swansea, United Kingdom
18Ludwig Institute for Cancer Research, University of Oxford, Oxford, United Kingdom
19University of Edinburgh, Edinburgh, GBR
20Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, National Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, ENG, United Kingdom

4:15 PM

Jie Zhou1*, Heng Mei1*, Yanyan Xu2*, Jinhui Shu1*, Linlin Huang1*, Min Xu1*, Haojie Jiang2*, Junling Liu2* and Yu Hu, MD3*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

4:30 PM

Yuxiu Chen1*, Kai-Yan Liu, MD, PhD1,2,3, Haixia Fu, MD1,4* and Xiaohui Zhang, MD1,3,5,6,7,8,9*

1Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
2Peking University People’s Hospital, Beijing, China, Beijing, CHN
3Peking University People's Hospital, Beijing, China
4Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, Beijing, China
5Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China., Beijing, China
6Peking University people hospital, Beijing, China
7Collaborative Innovation Center of Hematology, Peking University, Beijing, China
8National Clinical Research Center for Hematologic Disease, Beijing, China
9Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

4:45 PM

Walter Wolfsberger Wolfsberger, PhD1*, Taras Oleksyk, PhD1* and Anthony Washington, PhD2

1Oakland University, Rochester, MI
2Department of Biology, Oakland University, Rochester, MI

5:00 PM

Yueyue Sun1,2*, Huan Tong1,2*, Lingyu Zeng1,2*, Kailin Xu1,2* and Jianlin Qiao, PhD1,3

1Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
2Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
3Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou City, Jiangsu Province, China

5:15 PM

Harvey G. Roweth, PhD, BSc1,2, Isabelle C. Becker, PhD2,3, Michael Malloy1*, Sophie Munn1*, Pryia Kumar2*, Alec A Schmaier, MD, PhD2,4 and Elisabeth Battinelli, MD, PhD1,2

1Brigham and Women's Hospital, Boston, MA
2Harvard Medical School, Boston, MA
3Boston Children's Hospital, Boston, MA
4Beth Israel Deaconess Medical Center, Boston, MA

*signifies non-member of ASH